Cargando…

Transplantation of Human Glial Progenitors to Immunodeficient Neonatal Mice with Amyotrophic Lateral Sclerosis (SOD1/rag2)

Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disease with no effective therapy. The neurodegenerative character of ALS was an appealing target for stem cell-based regenerative approaches. Different types of stem cells have been transplanted in both preclinical and clinical settings, b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanaszek, Luiza, Rogujski, Piotr, Drela, Katarzyna, Fiedorowicz, Michal, Walczak, Piotr, Lukomska, Barbara, Janowski, Miroslaw
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219833/ https://www.ncbi.nlm.nih.gov/pubmed/35739947 http://dx.doi.org/10.3390/antiox11061050

Ejemplares similares

SOD1/Rag2 Mice with Low Copy Number of SOD1 Gene as a New Long-Living Immunodeficient Model of ALS
por: Majchrzak, M., et al.
Publicado: (2019)

Myelin-Independent Therapeutic Potential of Canine Glial-Restricted Progenitors Transplanted in Mouse Model of Dysmyelinating Disease
por: Stanaszek, Luiza, et al.
Publicado: (2021)

Manganese-Labeled Alginate Hydrogels for Image-Guided Cell Transplantation
por: Araszkiewicz, Antonina M., et al.
Publicado: (2022)

Short-Lived Human Umbilical Cord-Blood-Derived Neural Stem Cells Influence the Endogenous Secretome and Increase the Number of Endogenous Neural Progenitors in a Rat Model of Lacunar Stroke
por: Jablonska, Anna, et al.
Publicado: (2015)

Mn-Based Methacrylated Gellan Gum Hydrogels for MRI-Guided Cell Delivery and Imaging
por: Vieira, Sílvia, et al.
Publicado: (2023)

Experimental Strategies of Mesenchymal Stem Cell Propagation: Adverse Events and Potential Risk of Functional Changes
por: Drela, Katarzyna, et al.
Publicado: (2019)

Challenges and Controversies in Human Mesenchymal Stem Cell Therapy
por: Lukomska, Barbara, et al.
Publicado: (2019)

MRI-guided intrathecal transplantation of hydrogel-embedded glial progenitors in large animals
por: Malysz-Cymborska, Izabela, et al.
Publicado: (2018)

A methylcellulose/agarose hydrogel as an innovative scaffold for tissue engineering
por: Niemczyk-Soczynska, Beata, et al.
Publicado: (2022)

The Role of Glia in Canine Degenerative Myelopathy: Relevance to Human Amyotrophic Lateral Sclerosis
por: Golubczyk, Dominika, et al.
Publicado: (2019)

Genetic Engineering of Mesenchymal Stem Cells to Induce Their Migration and Survival
por: Nowakowski, Adam, et al.
Publicado: (2016)

Traumatic brain injury does not disrupt costimulatory blockade-induced immunological tolerance to glial-restricted progenitor allografts
por: Wang, Rui, et al.
Publicado: (2021)

Mesenchymal stem cell engineering by ARCA analog-capped mRNA
por: Andrzejewska, Anna, et al.
Publicado: (2023)

Bone marrow-derived from the human femoral shaft as a new source of mesenchymal stem/stromal cells: an alternative cell material for banking and clinical transplantation
por: Drela, Katarzyna, et al.
Publicado: (2020)

Glial Cells in Amyotrophic Lateral Sclerosis
por: Lasiene, Jurate, et al.
Publicado: (2011)

Mesenchymal stem cells injected into carotid artery to target focal brain injury home to perivascular space
por: Andrzejewska, Anna, et al.
Publicado: (2020)

Hydrogel-based scaffolds to support intrathecal stem cell transplantation as a gateway to the spinal cord: clinical needs, biomaterials, and imaging technologies
por: Oliveira, J. Miguel, et al.
Publicado: (2018)

SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization
por: Banci, Lucia, et al.
Publicado: (2008)

Metal-deficient SOD1 in amyotrophic lateral sclerosis
por: Hilton, James B., et al.
Publicado: (2015)

Labeling of human mesenchymal stem cells with different classes of vital stains: robustness and toxicity
por: Andrzejewska, Anna, et al.
Publicado: (2019)

The COVID‐19 Menace
por: Walczak, Piotr, et al.
Publicado: (2021)

Is SOD1 loss of function involved in amyotrophic lateral sclerosis?
por: Saccon, Rachele A., et al.
Publicado: (2013)

Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis
por: Paré, Bastien, et al.
Publicado: (2018)

Pre- and postmortem imaging of transplanted cells
por: Andrzejewska, Anna, et al.
Publicado: (2015)

Structural and Functional Analysis of Human SOD1 in Amyotrophic Lateral Sclerosis
por: Moreira, Lorenna Giannini Alves, et al.
Publicado: (2013)

SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis
por: Tafuri, Francesco, et al.
Publicado: (2015)

SOD1 in Amyotrophic Lateral Sclerosis: “Ambivalent” Behavior Connected to the Disease
por: Pansarasa, Orietta, et al.
Publicado: (2018)

Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis
por: Alshikho, Mohamad J., et al.
Publicado: (2016)

Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
por: Filipi, Tereza, et al.
Publicado: (2020)

FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
por: Kabashi, Edor, et al.
Publicado: (2011)

Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis
por: Vehviläinen, Piia, et al.
Publicado: (2014)

Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
por: Jeon, Gye Sun, et al.
Publicado: (2018)

SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity
por: Berdyński, Mariusz, et al.
Publicado: (2022)

Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms
por: Xie, Manling, et al.
Publicado: (2023)

Long-Term MRI Cell Tracking after Intraventricular Delivery in a Patient with Global Cerebral Ischemia and Prospects for Magnetic Navigation of Stem Cells within the CSF
por: Janowski, Miroslaw, et al.
Publicado: (2014)

Translation, but not transfection limits clinically relevant, exogenous mRNA based induction of alpha-4 integrin expression on human mesenchymal stem cells
por: Nowakowski, Adam, et al.
Publicado: (2017)

Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells
por: Pokrishevsky, Edward, et al.
Publicado: (2017)

Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
por: Nizzardo, M., et al.
Publicado: (2016)

Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice
por: Juranek, Judyta K., et al.
Publicado: (2016)

Copper Homeostasis as a Therapeutic Target in Amyotrophic Lateral Sclerosis with SOD1 Mutations
por: Tokuda, Eiichi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qan69dpdla79cfur32ht5alfuc